| Corrigendum: Late-stage MC38 tumours recapitulate features of human colorectal cancer–implications for appropriate timepoint selection in preclinical studies NJ Shields, EM Peyroux, AL Ferguson, M Steain, S Neumann, SL Young Frontiers in Immunology 15, 1430460, 2024 | | 2024 |
| Dendritic cell–specific intercellular adhesion molecule‐3‐grabbing nonintegrin (DC‐SIGN) is a cellular receptor for delta inulin adjuvant EL Stewart, C Counoupas, M Steain, C Ashley, S Alca, L Hartley‐Tassell, ... Immunology and Cell Biology, 2024 | | 2024 |
| Australia’s COVID-19 vaccine journey: progress and future perspectives JA Triccas, MC Steain Microbiology Australia 45 (1), 27-31, 2024 | 1 | 2024 |
| Late-stage MC38 tumours recapitulate features of human colorectal cancer–implications for appropriate timepoint selection in preclinical studies NJ Shields, EM Peyroux, AL Ferguson, M Steain, S Neumann, SL Young Frontiers in Immunology 14, 1152035, 2023 | 1 | 2023 |
| Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis D Cromer, M Steain, A Reynaldi, TE Schlub, SR Khan, SC Sasson, ... Nature Communications 14 (1), 1633, 2023 | 52 | 2023 |
| Correlates of protection, thresholds of protection, and immunobridging among persons with SARS-CoV-2 infection DS Khoury, TE Schlub, D Cromer, M Steain, Y Fong, PB Gilbert, ... Emerging Infectious Diseases 29 (2), 381, 2023 | 71 | 2023 |
| Varicella Zoster Virus Impairs Expression of the Nonclassical Major Histocompatibility Complex Class I–Related Gene Protein (MR1) SK Purohit, C Samer, HEG McWilliam, R Traves, M Steain, BP McSharry, ... The Journal of Infectious Diseases 227 (3), 391-401, 2023 | 13 | 2023 |
| A unique cytotoxic CD4+ T cell‐signature defines critical COVID‐19 S Baird, CL Ashley, F Marsh‐Wakefield, S Alca, TM Ashhurst, ... Clinical & Translational Immunology 12 (8), e1463, 2023 | | 2023 |
| Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice AS Ashhurst, MD Johansen, JWC Maxwell, S Stockdale, CL Ashley, ... Nature Communications 13 (1), 6972, 2022 | 15 | 2022 |
| Assessing the suitability of long non-coding RNAs as therapeutic targets and biomarkers in SARS-CoV-2 infection Y Zhong, CL Ashley, M Steain, SF Ataide Frontiers in molecular biosciences 9, 975322, 2022 | 8 | 2022 |
| Relating in vitro neutralization level and protection in the CVnCoV (CUREVAC) trial D Cromer, A Reynaldi, M Steain, JA Triccas, MP Davenport, DS Khoury Clinical Infectious Diseases 75 (1), e878-e879, 2022 | 24 | 2022 |
| Neutralising antibodies predict protection from severe COVID-19 D Cromer, M Steain, A Reynaldi, TE Schlub, SC Sasson, SJ Kent, ... medRxiv, 2022.06. 09.22275942, 2022 | 13 | 2022 |
| Mucosal immunization with a delta-inulin adjuvanted recombinant spike vaccine elicits lung-resident immune memory and protects mice against SARS-CoV-2 EL Stewart, C Counoupas, MD Johansen, DH Nguyen, S Miemczyk, ... Mucosal immunology 15 (6), 1405-1415, 2022 | 8 | 2022 |
| Modulation of Apoptosis and Cell Death Pathways by Varicella-Zoster Virus M Steain, B Slobedman, A Abendroth Varicella-zoster Virus: Genetics, Pathogenesis and Immunity, 59-73, 2022 | 1 | 2022 |
| The RHIM of the immune adaptor protein TRIF forms hybrid amyloids with other necroptosis-associated proteins MODG Baker, N Shanmugam, CLL Pham, SR Ball, E Sierecki, Y Gambin, ... Molecules 27 (11), 3382, 2022 | 3 | 2022 |
| High-titer neutralizing antibodies against the SARS-CoV-2 delta variant induced by alhydroxyquim-ii-adjuvanted trimeric spike antigens C Counoupas, P Pino, AO Stella, C Ashley, H Lukeman, ... Microbiology Spectrum 10 (1), e01695-21, 2022 | 12 | 2022 |
| Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis D Cromer, M Steain, A Reynaldi, TE Schlub, AK Wheatley, JA Juno, ... The Lancet Microbe 3 (1), e52-e61, 2022 | 504 | 2022 |
| A meta-analysis of early results to predict vaccine efficacy against Omicron DS Khoury, M Steain, JA Triccas, A Sigal, MP Davenport, D Cromer MedRxiv, 2021.12. 13.21267748, 2021 | 59 | 2021 |
| A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection C Counoupas, MD Johansen, AO Stella, DH Nguyen, AL Ferguson, ... npj Vaccines 6 (1), 143, 2021 | 52 | 2021 |
| SARS-CoV-2 variants: levels of neutralisation required for protective immunity D Cromer, M Steain, A Reynaldi, TE Schlub, AK Wheatley, JA Juno, ... medRxiv, 2021.08. 11.21261876, 2021 | 18 | 2021 |
